Non‐invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy
Authors:
Open Access
- 10 July 2014
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 45 (1) , 55-60
Abstract
Objectives To evaluate the feasibility of non‐invasive prenatal testing (NIPT) of maternal plasma samples collected from pregnant Chinese women in early gestation, between 8 + 0 and 12 + 6 weeks' gestation. Methods In this pilot study, 212 women with high‐risk pregnancies were recruited at a single Chinese Hospital. Fetal aneuploidies associated with chromosomes 21, 18, 13, X and Y were detected by massively parallel sequencing of maternal plasma DNA samples. Invasive prenatal diagnosis by either chorionic villus sampling or amniocentesis and then karyotyping was offered to all women to confirm both positive and negative NIPT results. Fetal DNA fraction was also determined in male pregnancies, by the relative percentage of Y‐chromosome sequences. All confirmed NIPT‐negative pregnancies were followed up to birth and neonates were clinically evaluated for any symptoms of chromosomal disease. Results Autosomal aneuploidies trisomy 21 (n = 2), 18 (n = 1) and 13 (n = 1) were detected by NIPT and confirmed by amniocentesis and karyotyping. There were one false‐positive 45,X sample and two false‐negative samples associated with fetal karyotypes 47,XXY and 45,X[16]/47,XXX[14]. In the 100 male pregnancies, the median fetal DNA fraction was 8.54% and there was a trend towards an increasing fetal fraction from 8 + 0 to 12 + 6 weeks' gestation. The majority (95%) of pregnancies had a fetal DNA fraction > 4%, which is generally the limit for accurate aneuploidy detection by NIPT. Across this early gestational time period, there was a weak inverse relationship (R2 = 0.186) between fetal DNA fraction and maternal weight. Conclusions NIPT is highly reliable and accurate when applied to maternal DNA samples collected from pregnant women in the first trimester between 8 + 0 and 12 + 6 weeks. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening resultsGenetics in Medicine, 2014
- DNA Sequencing versus Standard Prenatal Aneuploidy ScreeningNew England Journal of Medicine, 2014
- Non‐invasive prenatal testing for fetal chromosomal abnormalities by low‐coverage whole‐genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single centerUltrasound in Obstetrics & Gynecology, 2014
- False‐negative trisomy 18 non‐invasive prenatal test result due to 48,XXX,+18 placental mosaicismUltrasound in Obstetrics & Gynecology, 2013
- Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicismGenetics in Medicine, 2013
- Two cases of placental T21 mosaicism: challenging the detection limits of non‐invasive prenatal testingPrenatal Diagnosis, 2013
- Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese populationPrenatal Diagnosis, 2013
- Non‐invasive prenatal testing for aneuploidy: current status and future prospectsUltrasound in Obstetrics & Gynecology, 2013
- The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidiesPrenatal Diagnosis, 2013
- Non‐invasive prenatal testing with cell‐free DNA: US physician attitudes toward implementation in clinical practicePrenatal Diagnosis, 2013